(Q37920931)

25 August 2017

1 reference

title

Clinically relevant anti-epileptic drug interactions (English)

1 reference

25 August 2017

F Pisani

1

1 reference

PubMed ID

2185961

25 August 2017

E Perucca

series ordinal

2

1 reference

PubMed ID

2185961

25 August 2017

R Di Perri

series ordinal

3

1 reference

25 August 2017

1 January 1990

1 reference

Journal of International Medical Research

25 August 2017

1 reference

25 August 2017

18

1 reference

25 August 2017

1

1 reference

25 August 2017

1-15

1 reference

Interactions of Antiepileptic Drugs

25 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Interactions with Antiepileptic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Clinical Pharmacokinetics of Phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Use of phenytoin serum levels in a case of status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

The effects of sucralfate upon phenytoin absorption in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Antipyretic analgesics in patients on antiepileptic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Pharmacokinetic investigation of the interaction of azapropazone with phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Erythrocyte uptake and plasma binding of diphenylhydantoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Interactions of valproic acid with phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Decreased plasma protein binding of phenytoin in patients on valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Intoxication Caused by Interaction of Chloramphenicol and Phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Interaction of chloramphenicol with phenytoin and phenobarbital. Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Interaction of phenytoin with chlorpheniramine [letter]

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

The interaction of denzimol (a new anticonvulsant) with carbamazepine and phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Interaction between phenytoin and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Methylphenidate Interaction With Both Anticonvulsants and Ethyl Biscoumacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Pharmacological Interactions of Mesuximide with Phenobarbital and Phenytoin in Hospitalized Epileptic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Inhibition of carbamazepine and phenytoin metabolism by nafimidone, a new antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Phenytoin intoxication induced by sulthiame in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Phenothiazine-induced phenytoin intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Folate therapy in epilepsy. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Interaction of nitrofurantoin with diphenylhydantoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Influence of rifampicin and isoniazid on the kinetics of phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Clinical Pharmacokinetics of Carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Carbamazepine neurotoxicity precipitated by diltiazem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Progabide-induced changes in carbamazepine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Carbamazepine-viloxazine interaction in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Possible hazard of valpromide-carbamazepine combination therapy in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Increased dipropylacetic acid bioavailability from dipropylacetamide by food.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Effect of erythromycin on carbamazepine kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Carbamazepine toxicity induced by concurrent erythromycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Clinically significant carbamazepine drug interactions: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Reversal by phenytoin of carbamazepine-induced water intoxication: a pharmacokinetic interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Kinetics of phenobarbital in normal subjects and epileptic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Antacid Therapy and Drug Kinetics1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Valproic acid fails to displace phenobarbitone and carbamazepine from plasma protein binding sites in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Drug Interactions During Anticonvulsant Therapy in Childhood: Diphenylhydantoin, Primidone, Phenobarbitone, Clonazepam, Nitrazepam, Carbamazepin and Dipropylacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Factors influencing plasma phenobarbitone levels in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Controlled trial of frusemide as an antiepileptic drug in focal epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

The distribution and excretion of phenobarbital

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Interaction of phenytoin and primidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

The effect of phenytoin and ethosuximide on primidone metabolism in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Plasma Levels of Primidone and Its Metabolite Phenobarbital

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Clinical pharmacokinetics of valproic acid--1988.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

The effect of aspirin on valproic acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Clinical valproate toxicity induced by acetylsalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Disposition of sodium valproate in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Effects of carbamazepine on valproic acid kinetics in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Cyclosporin-phenytoin interaction: re-evaluation using metabolite data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Renal insensitivity to frusemide caused by chronic anticonvulsant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Interaction between cyclosporin A and phenobarbitone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Pharmacokinetics of chlorpropamide in epileptic patients: effects of enzyme induction and urine pH on chlorpropamide elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Lignocaine disposition in blood in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Clinical Implications of Enzyme Induction and Enzyme Inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive‐drug interactions with anticonvulsants and antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Effect of diphenylhydantoin on the metabolism of dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

Complex partial seizures: EEG foci and response to carbamazepine and sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

The efficacy of carbamazepine combinations in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059001800102

10.1177/030006059001800102

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

2185961